Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device

Europace

Volumn 8, Issue 7, 2006, Pages 465-473

  Gulizia, Michele ^a   Mangiameli, Salvatore ^b   Orazi, Serafino ^c   Chiarandà, Giacomo ^d   Boriani, Giuseppe ^e   Piccione, Guglielmo ^f   DiGiovanni, Nicolò ^g   Colletti, Andrea ^h   Puntrello, Calogero ⁱ   Butera, Gaetano ^j   Vasco, Calogero ^k   Vaccaro, Ignazio ^l   Scardace, Giuseppe ^m   Grammatico, Andrea ^m  

^a Garibaldi Nesima Hospital   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

^c Cardiology Department   (Italy)

^d Muscatello Hospital   (United States)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f Civile Hospital   (Italy)

^g Abele Aiello Hospital   (Italy)

^h Civili Riuniti Hospital   (Italy)

ⁱ Azienda Ospedaliera S Antonio di Abate di Trapani   (Italy)

^j Clinica Noto Pasqualino   (Italy)

^k Umberto I Hospital   (Italy)

^l S Giovanni di Dio Hospital   (Italy)

^m Medtronic Italia   (Italy)

more..

Author keywords

Antitachycardia pacing; AT500; Atrial fibrillation; Burst+; Ramp; Termination efficacy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CYCLE; HEART PACING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINUS NODE DYSFUNCTION; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR TACHYCARDIA; THERAPY EFFECT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ARRHYTHMIA, SINUS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; CROSS-OVER STUDIES; FEMALE; HUMANS; ITALY; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; TACHYCARDIA; TREATMENT OUTCOME;

EID: 33745600374     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul055     Document Type: Article

References (45)

1. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999; 84:131R-138R.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946-952.
3. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein M, Alonso-Garcia A, Btomström-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive summary. Circulation 2001;104:2118-2150.
4. Fisher JD, Kim SG, Mercando AD. Electrical devices for treatment of arrhythmias. Am J Cardiol 1988;61:45A-57A.
5. Rosenthal ME, Josephson ME. Current status of antitachycardia devices. Circulation 1990;82:1889-1899.
6. Hii JT, Mitchell LB, Duff HJ, Wyse DG, Gillis AM. Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutter. Am J Cardiol 1992;70:463-467.
7. Dijkman B, Wettens HJJ. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11:1196-1205.
8. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hammill SC. Atrial therapies reduce atria arrhythmia burden in defibrillator patients. Circulation 2001;104:1023-1028.
9. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Toscano S, Miraglia F, Grammatico A, Santini M. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 2002; 23:1471-1479.
10. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto GL, Boriani G, Miraglia F, De Santo T, Santini M. Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: The 7250 Dual Defibrillator Italian Registry. Eur Heart J 2001;3(Suppl. P):P25-P32.
11. Disertori M, Padeletti L, Santini M, Dini P, Gasparini M, Inama G, Botto GL, Boriani G, Capucci A, Ricci R, Gramigna L, Del Greco M, Grammatico A, Vimercati M. Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: The AT500 Italian Registry. Eur Heart J 2001;3(Suppl. P):P16-P24.
12. Israel CW, Hugl B, Unterberg C, Lawo T, Kennis I, Hettrick D, Hohnloser SH. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128.
13. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.
14. Hugl B, Israel CW, Unterberg C, Lawo T, Geller JC, Kennis IM, Euler DE, Koehler JL, Hettrick DA. Incremental programming of atrial antitachycardia pacing therapies in bradycardia-indicated patients: effects on therapy efficacy and atrial tachyarrhythmia burden. Europace 2003;5:403-409.
15. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-1216.
16. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang ASL, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385-1391.
17. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation 2003;107:1614-1619.
18. Capucci A, Santini M, Padeletti L, Gulizia M, Botto GL, Boriani G, Ricci R, Favate S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico M. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-1192.
19. Gillis AM, Koehler J, Morck M, Mehra R, Hettrick DA. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm 2005;2:791-796.
20. Swerdlow CD, Schöls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD. Detection of atrial fibrillation and flutter by a dual chamber implantable cardioverter-defibrillator. Circulation 2000; 101:878-885.
21. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg JM, DeSouza CM. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001;103:381-386.
22. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
23. Zeger S, Liang KY, Albert PS. Models for longitudinal data: A generalized estimation equation approach. Biometrics 1988;44:1049-1060.
24. Waldo AL, MacLean WA, Karp RB, Kouchoukos NT, James TN. Continuous rapid atrial pacing to control recurrent or sustained supraventricular tachycardias following open heart surgery. Circulation 1976;54:245-250.
25. Waldo AL, Henthorn RW, Plumb VS, MacLean WAH. Demonstration of the mechanism of transient entrainment and interruption of ventricular tachycardia with rapid atrial pacing. J Am Coll Cardiol 1984;3:422-427.
26. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Santini M, Wolfe K, Kavaney DJ, Otterness MF, Hohnloser SH. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653-1659.
27. Adler S, Wolpert C, Warman E Musley SK, Koehler JL, Euler DE. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001;104:887-892.
28. Stambler BS, Wood MA, Ellenbogen KA. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit. J Am Coll Cardiol 1996;27:453-461.
29. Tai CT, Chen SA, Feng AN, Yu WC, Chen YJ, Chang MS. Electrophysiologic effect of class I and class III antiarrhythmic drugs on typical atrial flutter. Insights into the mechanism of termination. Circulation 1998; 97:1935-1945.
30. Wijffels MCEF, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat. Effects of cibenzoline, hydroquinidine, flecainide, and D-sotalol. Circulation 2000;102:260-267.
31. Kirchhof C, Chorro F, Scheffer GJ, Brugada J, Konings K, Zetelaki Z, Allessie M. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs. Circulation 1993;88:736-749.
32. Capucci A, Ravelli F, Nollo G, Montenero AS, Biffi M, Villani GQ. Capture window in human atrial fibrillation: Evidence of an excitable gap. J Cardiovasc Electrophysiol 1999;10:319-327.
33. Charos GS, Haffajee CI, Gold RL, Bishop RL, Berkovits BV, Alpert JS. A theoretically and practically more effective method for interruption of ventricular tachycardia: Self-adapting autodecremental overdrive pacing. Circulation 1986;73:309-315.
34. Jung W, Mletzko R, Manz M. Comparison of two antitachycardia pacing modes in supraventricular tachycardia. Pacing Clin Electrophysiol 1991; 14:1762-1766.
35. Crawford W, Plumb VJ, Epstein AE, Kay GN. Prospective evaluation of transesophageal, pacing for the interruption of atrial flutter. Am J Med 1989;86:663-667.
36. D'Este D, Bertaglia E, Mantovan R, Zanocco A, Franceschi M, Pascotto P. Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective. Am J Cardiol 1997;79:500-502.
37. Olshansky B, Okumura K, Hess PG, Henthorn RW, Waldo AL. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm. J Am Coll Cardiol 1988;11:359-364.
38. Daoud EG, Pariseau B, Niebauer M, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Response of type I atrial fibrillation to atrial pacing in humans. Circulation 1996;94:1036-1040.
39. Pandozi C, Bianconi L, Villani M, Castro A, Altamura G, Toscana S, Jesi AP, Gentilucci G, Ammirati F, Lo Bianco F, Santini M. Local capture by atrial pacing in spontaneous chronic atrial fibrillation. Circulation 1997; 95:2416-2422.
40. Konings KTS, Kirchhof CJHJ, Smeets JRLM. High density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89: 1665-1680.
41. Saksena S, Prakash A, Krol RB, Shankar A. Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol 1999; 84:880-889.
42. Israel CW, Ehrlich JR, Groenefeld G, Klesius A, Lawo T, Lemke B, Hohnloser SH. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol 2001;38:355-363.
43. Ndrepepa G, Weber S, Karch MR, Schneider MA, Schreieck JJ, Schomig A, Schmitt C. Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation. Am J Cardiol 2002;90: 1215-1220.
44. Padeletti L, Santini M, Boriani G, Botto GL, Capucci A, Gutizia M, Ricci R, Spampinato A, Pieragnoli P, Warman E, Vimercati M, Grammatico A. Temporal variability of atrial tachyarrhythmia burden in bradycardiatachycardia syndrome patients. Eur Heart J 2005;26:165-172.
45. Boriani G, Padeletti L, Santini M, Gulizia M, Capucci A, Botto G, Ricci R, Molon G, Accogli M, Vicentini A, Biffi M, Vimercati M, Grammatico A. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol 2005;16:714-723.